menu
    • menu

    Company profile for Windtree Therapeutics

    NEW Drugs in Dev: 4
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Windtree Therapeutics Inc. is a biotechnology company focused on developing novel KL4 surfactant therapies for respiratory diseases and other potential applications. Windtree’s proprietary technology platform includes a synthetic, treatment peptide-containing surfactant (KL4 surfactant ) that is structurally similar to human pulmonary surfactant — and novel drug-delivery technologies that are being developed to enable non...
    Windtree Therapeutics Inc. is a biotechnology company focused on developing novel KL4 surfactant therapies for respiratory diseases and other potential applications. Windtree’s proprietary technology platform includes a synthetic, treatment peptide-containing surfactant (KL4 surfactant ) that is structurally similar to human pulmonary surfactant — and novel drug-delivery technologies that are being developed to enable noninvasive administration of aerosolized KL4 surfactant.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Windtree TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2600 Kelly Road, Suite 100 Warrington, PA 18976-3622
    Telephone
    Telephone
    215-488-9300
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://windtreetx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CGT Asia

    Not Confirmed

    envelop Contact Supplier

    CGT Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Panacea Forms Seismic Pharma For Clinical Heart Failure Portfolio
    Panacea Forms Seismic Pharma For Clinical Heart Failure Portfolio

    30 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/panacea-capital-leads-formation-of-seismic-pharma-to-advance-novel-clinical-stage-heart-failure-portfolio-302728098.html

    PR NEWSWIRE
    30 Mar 2026
    Share Share
    Windtree Therapeutics Sells Cardiovascular Biotech Pipeline Drugs
    Windtree Therapeutics Sells Cardiovascular Biotech Pipeline Drugs

    23 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/23/3209932/0/en/Windtree-Therapeutics-Announces-the-Sale-of-its-Cardiovascular-Biotech-Pipeline-Drug-Candidates.html

    GLOBENEWSWIRE
    23 Dec 2025
    Share Share
    Windtree Therapeutics Signs Letter Of Intent To Acquire CommLoan
    Windtree Therapeutics Signs Letter Of Intent To Acquire CommLoan

    03 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/03/3198943/0/en/Windtree-Therapeutics-Announces-It-Has-Signed-a-Letter-of-Intent-to-Acquire-CommLoan-Inc-a-Revenue-Generating-Company-in-the-Rapidly-Growing-Fintech-Space.html

    GLOBENEWSWIRE
    03 Dec 2025
    Share Share
    Windtree Therapeutics To Receive License Agreement Payments
    Windtree Therapeutics To Receive License Agreement Payments

    17 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/17/3189210/0/en/Windtree-Therapeutics-Announces-It-May-Receive-License-Agreement-Payments-from-Its-Licensee-for-Renewed-Acute-Pulmonary-Development-by-the-Licensee.html

    GLOBENEWSWIRE
    17 Nov 2025
    Share Share
    Windtree Therapeutics Enhances Istaroxime Patent Portfolio
    Windtree Therapeutics Enhances Istaroxime Patent Portfolio

    14 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/14/3188356/0/en/Windtree-Therapeutics-Announces-More-Strengthening-of-Its-Istaroxime-and-Next-Generation-SERCA2a-activator-Patent-Estate.html

    GLOBENEWSWIRE
    14 Nov 2025
    Share Share
    Windtree To Receive $7.5M From Recent Termination Agreement
    Windtree To Receive $7.5M From Recent Termination Agreement

    13 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/13/3187721/0/en/Windtree-Therapeutics-Announces-It-Will-Receive-7-5-Million-In-Cash-and-Securities-from-the-Recently-Executed-Termination-Agreement-with-an-Environmental-Services-Company.html

    GLOBENEWSWIRE
    13 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search